Simulations Plus News
News
0
Ticker
SLP
ISIN
US8292141053
Simulations Plus Eulerpool News
Simulations Plus Stock News
Simulations Plus is being monitored by journalists and investors worldwide. We gather the latest Simulations Plus news here.
- February 10·Benzinga
- January 21·Yahoo
- January 21·SeekingAlpha
- January 20·Yahoo
- January 8·Benzinga
- December 18·Yahoo
- December 18·Yahoo
- December 9·Yahoo
- December 9·Benzinga
- December 9·SeekingAlpha
- December 4·Yahoo
- December 2·SeekingAlpha
- December 2·Yahoo
- December 1·Yahoo
- December 1·SeekingAlpha
- November 24·Yahoo
- November 7·Yahoo
- October 29·Yahoo
- October 22·Yahoo
- September 30·Benzinga
Simulations Plus Stock Press Releases
Simulations Plus regularly publishes news on the company's website that are relevant for investors.
- August 4•Simulations Plus
- July 26•Simulations Plus
- July 21•Simulations Plus
- July 14•Simulations Plus
- July 6•Simulations Plus
- June 30•Simulations Plus
- June 23•Simulations Plus
- June 21•Simulations Plus
- June 16•Simulations Plus
- May 26•Simulations Plus
- May 5•Simulations Plus
- April 28•Simulations Plus
- April 21•Simulations Plus
- April 19•Simulations Plus
- April 6•Simulations Plus
- March 29•Simulations Plus
- March 24•Simulations Plus
- March 22•Simulations Plus
- March 17•Simulations Plus
- March 10•Simulations Plus
- March 8•Simulations Plus
- March 2•Simulations Plus
- February 8•Simulations Plus
- January 20•Simulations Plus
- January 13•Simulations Plus
- January 12•Simulations Plus
- January 6•Simulations Plus
- January 5•Simulations Plus
- December 20•Simulations Plus
- December 2•Simulations Plus
Simulations Plus News 2026
This page contains all current news, analysis and press releases for Simulations Plus stock (SLP, ISIN: US8292141053). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Simulations Plus.
Simulations Plus Stock
Simulations Plus Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health."